Sparteine sulfate
CAS No. 299-39-8
Sparteine sulfate( —— )
Catalog No. M18386 CAS No. 299-39-8
Sparteine sulfate is a class 1a antiarrhythmic agent and a sodium channel blocker. It can chelate the bivalents calcium and magnesium.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 95 | Get Quote |
|
| 10MG | 170 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSparteine sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSparteine sulfate is a class 1a antiarrhythmic agent and a sodium channel blocker. It can chelate the bivalents calcium and magnesium.
-
DescriptionSparteine sulfate is a class 1a antiarrhythmic agent and a sodium channel blocker. It can chelate the bivalents calcium and magnesium.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorSodium Channel
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number299-39-8
-
Formula Weight332.46
-
Molecular FormulaC15H28N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(=O)(O)O.C1CCCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@@H]12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gawali VS, et al. C2-Modified Sparteine Derivatives Are a New Class of Potentially Long-Acting Sodium Channel Blockers. ChemMedChem. 2017 Nov 22;12(22):1819-1822.
molnova catalog
related products
-
Icrucumab
Icrucumab ( IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.
-
Fruquintinib
A potent and highly selective small molecule inhibitor of VEGFR1/2/3 with IC50 of 33/3/5/0.5 nM, respectively.
-
Lenvatinib
Lenvatinib (E7080) is a multitargeted kinase inhibitor with IC50s of 4/5.2/22/46 nM for VEGFR2/VEGFR3/VEGFR1/FGFR1 in cell free assays.
Cart
sales@molnova.com